1:39 PM
 | 
Feb 25, 2019
 |  BC Extra  |  Financial News

Gracell raises $85M series B to advance cell therapies

Temasek led an $85 million series B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures, Kington Capital, King Star Capital and...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >